Anti-Smad3 antibody [EP568Y] (Ab40854)
MADH3, SMAD3, SMAD family member 3, SMAD 3, hSMAD3, JV15-2, Mothers against decapentaplegic homolog 3, MAD homolog 3, Mad3, Mothers against DPP homolog 3, hMAD-3
详细信息
背景信息
What is this antibody validated in? Anti-Smad3 antibody [EP568Y] (ab40854) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, Rat samples. What is the molecular weight of Smad3? Anti-Smad3 [EP568Y] (ab40854) specifically detects a band for Smad3 (UniProt: P84022) at a molecular weight of 48kDa. Trusted by the scientific community Anti-Smad3 [EP568Y] (ab40854) was first used in a scientific publication in 2006 and has been cited over 300 times in peer-reviewed journals. Reviewed by scientists Anti-Smad3 [EP568Y] (ab40854) has over 10 independent reviews from customers. Specificity confirmed The specificity of Anti-Smad3 antibody [EP568Y] (ab40854) has been confirmed by Western blot testing in SMAD3 Knockout A549 cells. Other related products We have a range of other formats of antibody clone [EP568Y] also available for your convenience: ab40854, Carrier free - ab157372, Alexa Fluor ® 488 - ab204257, Alexa Fluor ® 647 - ab204461, HRP - ab204462, Alexa Fluor ® 594 - ab206350, Alexa Fluor ® 555 - ab206582, PE - ab208751 Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (321)
Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy.
生物工程外泌体-mRNA杂交体:糖尿病肾纤维化治疗中靶向miRNA递送的突破。
Elevated circulating GDF11 and its role in age-related sarcopenia: insights from clinical, transcriptomic, and in vitro analyses.
循环中 GDF11 水平升高及其在年龄相关性肌肉减少症中的作用:来自临床、转录组学和体外分析的见解。
Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR-133a and Downregulating TGF-β/Smads Signal Molecules.
益逍方通过上调 miR-133a 和下调 TGF-β/Smads 信号分子抑制心肌纤维化。
PTTG1 regulates the TGF-β/Smad pathway to promote the growth and metastasis of gastric cancer cells.
PTTG1 调节 TGF-β/Smad 通路,促进胃癌细胞的生长和转移。
Mechanical confinement governs phenotypic plasticity in melanoma
机械限制调控黑色素瘤的表型可塑性
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth
使用嗜铬粒蛋白 A 衍生肽阻断 αvβ6 和 αvβ8 整合素可抑制肿瘤中的 TGFβ 活化并抑制肿瘤生长
TGF-β1/SMAD3-mediated Non-canonical Hedgehog Signaling Promotes Pancreatic Stellate Cell Activation and Fibrosis in Chronic Pancreatitis.
TGF-β1/SMAD3介导的非经典Hedgehog信号通路促进慢性胰腺炎中胰腺星状细胞活化和纤维化。
Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells.
靶向 SMAD3/CISD2 轴可促进间质样膀胱癌细胞发生铁死亡,从而抑制膀胱癌的进展。
Cellular senescence promotes macrophage-to-myofibroblast transition in chronic ischemic renal disease.
细胞衰老促进慢性缺血性肾病中巨噬细胞向肌成纤维细胞的转化
Fibrogenesis-driven tumor progression in clear cell renal cell carcinoma: prognostic, therapeutic implications and the dual role of neuropilin-1.
纤维生成驱动的透明细胞肾细胞癌肿瘤进展:预后、治疗意义以及神经纤毛蛋白-1的双重作用
- 1
- 2
- 3
- 4
- 5
- 6
- 33